CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 10, 2022 · earnings

NPCE earnings: a negative outcome, -6.6%

On March 10, 2022, NeuroPace Inc reached its earnings. The result was a negative outcome, and the stock moved -6.6% in the window around the event. It had already run -12.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$8.15
1d before
$7.61
Event day
$8.08
1d after
$7.52
5d after

Pre-catalyst setup

-12.0%
30-day run-up
6595%
30-day volatility
0.4×
volume spike